Accès ouvert
2023
article
OpenAlex
Sivagurunathan Sutharsan, Stefanie Dillenhoefer, Matthias Welsner, Florian Stehling et autres
Treatment with elexacaftor/tezacaftor/ivacaftor (ETI) improves multiple clinical outcomes in people with cystic fibrosis (pwCF) with at least one F508del allele. This study evaluated the real-world impact of ETI on lung function, nutritional status, pulmonary exacerbation frequency, and sweat chloride concentrations in a …
de, at
(code pays fourni par la source)
2016
article
OpenAlex
Lars Lange, L. Lasota, Antje Finger, Dejan Vlajnic et autres
INTRODUCTION: Component-resolved diagnostics using specific IgE to 2 S albumins has shown to be a valuable new option in diagnostic procedure. Ana o 3 is a 2 S albumin from cashew. The aim of this study was to investigate the role of …
de
(code pays fourni par la source)
Accès ouvert
2015
article
OpenAlex
Carolin I. Kröner, Simone Reu, Veronika I. Teusch, Andrea Schams et autres
Patients with interstitial lung disease due to surfactant protein C (SFTPC) mutations are rare and not well characterised. We report on all subjects collected over a 15-year period in the kids-lung register with interstitial lung disease and a proven SFTPC mutation. We …
de, nl, be, tr
(code pays fourni par la source)
Accès ouvert
2014
article
OpenAlex
Sylvia Lehmann, Claus Pfannenstiel, Frank Friedrichs, Kristina Kröger et autres
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a severe complication in patients with cystic fibrosis (CF), resulting in deterioration of lung function and impairment of overall prognosis. Standard therapy consists of high dosage, long-term corticosteroid treatment. This carries the risk of serious side …
de
(code pays fourni par la source)
2014
article
OpenAlex
Claus Pfannenstiel, Frank Friedrichs
de
(code pays fourni par la source)
2011
conference-abstract
OpenAlex
Ann-Christin Grimmelt, Michael G. Barker, Frank E. Brasch, Monika Gappa et autres
Genetic variations of SP-C gene are known to cause interstitial lung disease. In previous studies 55 patients have been described focussing on the genetic abnormalities and clinical course. Here we report the data of children with SP-C mutations collected between 1998 and …
de
(code pays fourni par la source)
2008
article
OpenAlex
Lars Lange, Isidor Huttegger, Armin Grübl, Claus Pfannenstiel et autres
2004
article
OpenAlex
Michael G. Barker, Daniel Thoenes, Hiltrud Döhmen, Frank Friedrichs et autres
Venous thrombosis in children and young adults is frequently associated with predisposing conditions and with an indwelling catheter or totally implantable venous access device (TIVAD). These systems are commonly used for the delivery of antibiotic therapy in patients with cystic fibrosis (CF). …
de
(code pays fourni par la source)
2004
article
OpenAlex
Claus Pfannenstiel
de
(code pays fourni par la source)
2004
article
OpenAlex
Michael G. Barker, Egbert Franke, Martin Böhle, Claus Pfannenstiel et autres
DNase can reduce viscosity and facilitate expectoration of airway secretions in cystic fibrosis (CF) lung disease. We evaluated its effect on exercise performance in relation to resting pulmonary function. Fifteen sputum-producing CF patients (aged 9-28 years; FEV1 22-83% predicted) performed spirometry, body …
de
(code pays fourni par la source)
2003
article
OpenAlex
H. Brost, Hagen Ott, Claus Pfannenstiel, T. G. Wenzl et autres
de
(code pays fourni par la source)
1995
book-chapter
OpenAlex
Rolf W. Günther, Dierk Vorwerk, Claus Pfannenstiel